Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Interpace Diagnostics Group (IDXG) Stock Price & Analysis

IDXG Stock Chart & Stats

$5.59-$0.13(-2.24%)
At close: 4:00 PM EDT
$5$6$7$83 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$5.59 - $5.59
52-Week Range
$4.03 - $12.00
Previous Close
$5.72
Volume
N/A
Average Volume (3M)
1,583
Market Cap
$33.01M
Enterprise Value
$43.46M
Total Cash (Recent Filing)
$2.69M
Total Debt (Recent Filing)
$974.00K
Price to Earnings (P/E)
0.2
Beta
1.93
Next Earnings
Nov 11, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet Strength

Positive equity and very low debt materially improve financial flexibility after several years of weaker balance-sheet metrics. This reduces leverage pressure, supports continued operations, and gives the company more capacity to fund priorities or absorb business volatility over the next several quarters.

Profitability Turnaround

The shift from sizable historical losses to sustained profitability through 2023–2025 and the TTM period indicates meaningful operational improvement. If maintained, positive operating income and strong gross profit can support internal funding and strengthen the company’s competitive position.

Positive Cash Generation

Positive operating and free cash flow provide tangible support for the reported earnings and reduce reliance on external financing. Free cash flow being close to net income is generally a favorable quality signal, giving the business resources to sustain operations and pursue its plans.

Bears Say

Declining Revenue

Falling revenue weakens the foundation for durable earnings growth and may limit operating leverage in the clinical diagnostics business. Continued contraction could pressure future cash generation, reduce resources available for investment, and make the recent profitability improvement harder to sustain.

Weakening Cash Conversion

Cash generation remains positive, but the deterioration in TTM cash-flow momentum and operating cash flow below net income raises questions about earnings quality. If this gap persists, reported profitability may translate less effectively into funds available for reinvestment and financial resilience.

Earnings Predictability

The combination of shrinking revenue and an unusually high net profit margin makes the current earnings run-rate less predictable. Potential non-core influences could reduce the durability of reported profits, complicating planning and increasing the risk that future results normalize below recent levels.

Interpace Diagnostics Group News

IDXG FAQ

What was Interpace Diagnostics Group’s price range in the past 12 months?
Interpace Diagnostics Group lowest stock price was $4.03 and its highest was $12.00 in the past 12 months.
What is Interpace Diagnostics Group’s market cap?
Interpace Diagnostics Group’s market cap is $33.01M.
When is Interpace Diagnostics Group’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Interpace Diagnostics Group’s earnings last quarter?
Interpace Diagnostics Group released its earnings results on Aug 10, 2026. The company reported $0.028 earnings per share for the quarter.
Is Interpace Diagnostics Group overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Interpace Diagnostics Group pay dividends?
Interpace Diagnostics Group does not currently pay dividends.
What is Interpace Diagnostics Group’s EPS estimate?
Interpace Diagnostics Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Interpace Diagnostics Group have?
Interpace Diagnostics Group has 5,901,962 shares outstanding.
What happened to Interpace Diagnostics Group’s price movement after its last earnings report?
Interpace Diagnostics Group reported an EPS of $0.028 in its last earnings report. Following the earnings report the stock price went down -1.824%.
Which hedge fund is a major shareholder of Interpace Diagnostics Group?
Currently, no hedge funds are holding shares in IDXG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology